5th Nordic RWE and AI conference – 28-29 January 2025, Helsinki
5th Nordic RWE and AI conference is organized by University of Helsinki and Åbo Akademi University. Register to the event here!
In 2011 Simo Jääskeläinen was Medaffcon’s first recruitment. A couple of years ago Simo spread his wings to tackle new challenges and further develop his experience in different Market Access positions.
Simo has more than 12 years of experience from the pharmaceutical industry.
Now in June, to our great joy, Simo returned to Medaffcon, taking on the responsibility of leading our Market Access team. We are glad to welcome Simo back “home”!
At Medaffcon, this experience from the pharmaceutical and medtech industries, already exceeds 130 working years, all of which is harnessed to find the best solutions for our customers. Due to our experience and over 400 Medaffcon projects, we understand our customers’ playing field probably better than any of our competitors!
5th Nordic RWE and AI conference is organized by University of Helsinki and Åbo Akademi University. Register to the event here!
Despite its high-risk nature and availability of kidney treatments, chronic kidney disease (CKD) often goes undiagnosed. This especially concerns patients without type 2 diabetes (T2D), who represent the majority of CKD patients. This finding comes from a recent registry study published in Nephrology Dialysis Transplantation (NDT).
Artificial intelligence (AI) is transforming research and working life across various industries. But what is its significance in health data analysis and real-world evidence (RWE) research? Medaffcon’s experts, Juhani Aakko and Lisse-Lotte Hermansson, share their perspectives on AI in their work.